Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma Labvantage - Biomax

Biomax Informatics and NeuroScios work together for better CNS clinical trial analysis

Posted on 16. March 20222. November 2022 by Firma Labvantage - Biomax Posted in General Tagged biomax, clinical trials, morphometry, neurodegeneration, neuroimaging, neuroscios

Today Biomax Informatics, Planegg, Germany and NeuroScios GmbH, St. Radegund, Austria announced their collaboration for advanced analysis of CNS clinical trials. Both partners were able to successfully demonstrate the valuable contribution of the neuroimaging software NICARA™ in the context of […]

Read More

Research consortium starts GENImmune project for new methods to design vaccines for efficient SARS-CoV-2 immunization

Posted on 22. February 20222. November 2022 by Firma Labvantage - Biomax Posted in Research / Development Tagged biomax, corona, covid-19, data mining, helmholtz, pepperprint, pmcr, Sars Cov2, vaccine, vaccines

Biomax Informatics, PEPperPRINT and PMCR today announced the launch of a joint research project with partners from the University of Bonn, the Helmholtz Munich and the Technical University of Munich. Under the name GENImmune the consortium will develop new methods […]

Read More

Biomax leads research project to improve diagnosis of heart failure

Posted on 3. November 20212. November 2022 by Firma Labvantage - Biomax Posted in Research / Development Tagged bioxm, dario, digital diagnostic support, hfpef

Today DARIO, a new research project for digital diagnostic support of heart failure, kicks-off. The project is coordinated by Biomax Informatics AG and partners with the Institute for Applied Medical Technology of the RWTH Aachen University and the Clinic for […]

Read More

Biomax Informatics: Universities use NeuroXM™ to study the connectome in drug-resistant epilepsy

Posted on 20. May 20212. November 2022 by Firma Labvantage - Biomax Posted in General Tagged connectomics, epilepsy, neuroimaging, neuroscience, Newcastle University

Using Biomax Informatics’ NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change in the connectome in drug-resistant epilepsy patients. They discovered that connectivity between and within brain regions can be […]

Read More

Biomax Informatics presents AILANI 2.0 for even more intelligent responses

Posted on 7. April 20212. November 2022 by Firma Labvantage - Biomax Posted in General Tagged artificial intelligence, data integration, digital transformation, digitalization, semantic search

Biomax Informatics announces the launch of version 2.0 of AILANI. AILANI 2.0 represents an even more modern and user-friendly version of Biomax Informatics’ semantic search platform. Via the new AILANI Cloud Interface, users can quickly and cost-effectively search through numerous […]

Read More

Biomax Informatics develops knowledge management solution NeuroCONNECT for Human Brain Project

Posted on 30. March 20212. November 2022 by Firma Labvantage - Biomax Posted in General Tagged connectomics, Ebrains, Human Brain Project, neuroimaging, neuroscience, Research Cooperation

Biomax Informatics today announced the development of a novel knowledge management and database solution NeuroCONNECT for EBRAINS, the digital research infrastructure created by the EU-funded Human Brain Project. NeuroCONNECT allows the semantic integration and management of multimodal brain connectivity information […]

Read More

Biomax Informatics presents NICARA—Your individual knowledge hub for neuroimaging data

Posted on 20. July 20202. November 2022 by Firma Labvantage - Biomax Posted in General Tagged aaic, alzheimer, biomax, brain science, connectomics, data integration, digitalization, neuroimaging, neurology, neuroscience, neuroxm, nicara, personalized medicine, software, virtual conference

Biomax Informatics today announced the presentation of NICARATM, a novel, unique and cost-effective neuroimaging solution focusing on Connectomics at the virtual AAIC Alzheimer’s Association International Conference from 27 to 31 July 2020. NICARA stands for NeuroImaging-based Connectome Assessment in Research […]

Read More

Biomax provides AI-based semantic search platform AILANI for COVID-19 free of charge and supports international efforts to fight coronavirus epidemics

Posted on 13. May 20202. November 2022 by Firma Labvantage - Biomax Posted in General Tagged ailani, biomax, corona, Corona research, Corona vaccine, coronavirus, covid, covid-19, data mining, disease map, Epidemie, SARS-CoV-2, semantic search

The bioinformatics company Biomax, headquartered in Planegg, Germany, makes its semantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful search for drugs and suitable vaccines against COVID-19 […]

Read More

Free Webinar and Live Demo of AILANI for Pharma and Biotech (Webinar | Online)

Posted on 27. January 202027. January 2020 by Firma Labvantage - Biomax Posted in Events Tagged knowledge management

The power of data comes from its context, meaning and the integration of multiple sources. AILANI for Pharma and Biotech achieves this by extracting inferred and hidden insights from your data. The search platform seamlessly integrates scientifically relevant resources with […]

Read More

Free Webinar and Live Demo of AILANI for Agro (Webinar | Online)

Posted on 27. January 202027. January 2020 by Firma Labvantage - Biomax Posted in Events Tagged Semantische Suche

Learn more about semantic search with AILANI and discover your own knowledge for deeper information during this free webinar for the Agriculture Industry: Topics: What is semantic search? How can AILANI help you to find better answers? What does Artificial […]

Read More

Posts navigation

Older posts

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more